Wells Fargo’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43 Buy
31
+21
+210% +$50 ﹤0.01% 6628
2025
Q4
$43 Hold
10
﹤0.01% 6550
2025
Q3
$118 Buy
10
+5
+100% +$87 ﹤0.01% 6373
2025
Q2
$116 Hold
5
﹤0.01% 6468
2025
Q1
$142 Hold
5
﹤0.01% 6351
2024
Q4
$331 Hold
5
﹤0.01% 6334
2024
Q3
$323 Hold
5
﹤0.01% 6200
2024
Q2
$427 Sell
5
-4
-44% -$176 ﹤0.01% 6157
2024
Q1
$434 Sell
9
-2
-18% -$158 ﹤0.01% 6310
2023
Q4
$1.52K Sell
11
-1
-8% -$175 ﹤0.01% 6142
2023
Q3
$2.35K Sell
12
-1
-8% -$209 ﹤0.01% 6071
2023
Q2
$2.58K Buy
13
+1
+8% +$239 ﹤0.01% 6179
2023
Q1
$3.03K Buy
12
+3
+33% +$842 ﹤0.01% 6165
2022
Q4
$2.24K Hold
9
﹤0.01% 5990
2022
Q3
$4K Buy
9
+3
+50% +$1.73K ﹤0.01% 5974
2022
Q2
$2K Buy
6
+1
+20% +$441 ﹤0.01% 6319
2022
Q1
$2K Hold
5
﹤0.01% 6672
2021
Q4
$7K Sell
5
-3
-38% -$4.45K ﹤0.01% 6634
2021
Q3
$12K Hold
8
﹤0.01% 6147
2021
Q2
$15K Sell
8
-20
-71% -$38.9K ﹤0.01% 6007
2021
Q1
$46K Buy
+28
New +$54.5K ﹤0.01% 5847
2020
Q4
Hold
0
6671

Other funds holding GOVX

Wells Fargo's GOVX Position: Q1 2026 in Review

Wells Fargo increased its GeoVax Labs (GOVX) stake by 210% in Q1 2026, buying an estimated $50 and bringing the position to 31 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #6628.

Wells Fargo first reported a position in GOVX in Q1 2021 and has held it in 21 quarters since. The position peaked at $46K in Q1 2021. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

  • Wells Fargo held 31 shares of GeoVax Labs worth $43 as of Q1 2026.
  • Wells Fargo bought 21 GeoVax Labs shares in Q1 2026, an estimated $50.
  • GeoVax Labs made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6628 holding.
  • Wells Fargo first reported a position in GeoVax Labs in Q1 2021 and has held it in 21 quarters since.
  • Wells Fargo's GeoVax Labs position peaked at $46K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.